Dirk van den Boom

Sequenom has appointed Dirk van den Boom as president and CEO. He will retain his seat on the company's board of directors. In September, van den Boom was appointed interim president and CEO. Before that, he served as chief scientific and strategy officer. He joined Sequenom in 1998 and has held various management roles within the research and development department.

Rick Klausner, Tristan Orpin, and more

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.